(Q46601074)

23 December 2017

title

Radioprotection in mice following oral delivery of amifostine nanoparticles (English)

1 reference

23 December 2017

0 references

7

1 reference

23 December 2017

author name string

Pamujula S

1

1 reference

23 December 2017

Kishore V

2

1 reference

23 December 2017

Rider B

3

1 reference

23 December 2017

Fermin CD

4

1 reference

23 December 2017

Graves RA

5

1 reference

23 December 2017

Agrawal KC

6

1 reference

23 December 2017

publication date

1 March 2005

1 reference

23 December 2017

International Journal of Radiation Biology

published in

1 reference

23 December 2017

volume

81

1 reference

23 December 2017

issue

3

1 reference

23 December 2017

page(s)

251-257

1 reference

23 December 2017

Chemical radioprotection: a critical review of amifostine as a cytoprotector in radiotherapy.

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09553000500103470

New dosing regimens for amifostine: a pilot study to compare the relative bioavailability of oral and subcutaneous administration with intravenous infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000500103470

Preclinical modeling of improved amifostine (Ethyol) use in radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000500103470

Increased therapeutic efficacy of zidovudine in combination with vitamin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000500103470

Phase I study of amifostine as a cytoprotector of the gemcitabine/cisplatin combination in patients with advanced solid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000500103470

Amifostine in clinical oncology: current use and future applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000500103470

Amifostine and external beam radiation therapy and/or high-dose rate brachytherapy in the treatment of localized prostate carcinoma: preliminary results of a phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000500103470

Clinical trial of endorectal amifostine for radioprotection in patients with prostate cancer: rationale and early results

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000500103470

Oral delivery of spray dried PLGA/amifostine nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000500103470

Preparation and in vitro characterization of amifostine biodegradable microcapsules

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000500103470

2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000500103470

Radioprotection, pharmacokinetic and behavioural studies in mouse implanted with biodegradable drug (amifostine) pellets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000500103470

Pilot study of subcutaneous amifostine in patients undergoing postoperative intensity modulated radiation therapy for head and neck cancer: preliminary data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000500103470

10.1080/09553000500103470

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017